Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Genotype 1a”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT02098616
What this trial is testing

Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Who this might be right for
Hepatitis C
Timothy Morgan, MD 25
Post-approval studies (Phase 4)Study completedNCT01937728
What this trial is testing

Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 542
Large-scale testing (Phase 3)Study completedNCT02476617
What this trial is testing

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 25
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Early research (Phase 1)Study completedNCT01928147
What this trial is testing

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Presidio Pharmaceuticals, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT02493855
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a
AbbVie 46
Testing effectiveness (Phase 2)Study completedNCT01859962
What this trial is testing

Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Presidio Pharmaceuticals, Inc. 38
Testing effectiveness (Phase 2)Study completedNCT01435226
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 170
Post-approval studies (Phase 4)Ended earlyNCT03797066
What this trial is testing

ATTIC - Access To Treat in the Community

Who this might be right for
Hepatitis C, Chronic
King's College Hospital NHS Trust 13
Large-scale testing (Phase 3)Study completedNCT01833533
What this trial is testing

Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 305
Large-scale testing (Phase 3)Study completedNCT02487199
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 18
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Large-scale testing (Phase 3)Study completedNCT02609659
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 105
Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163
Testing effectiveness (Phase 2)Ended earlyNCT01384383
What this trial is testing

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 248